Bli medlem
Bli medlem

Du är här


Cryo-Save Group N.V.: Convocation of extra-ordinary general meeting of shareholders to change name to Esperite N.V.

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the
leading international stem cell storage company and the largest family stem
cell bank in Europe, announces that, further to its 13 May 2014 announcement
that it shall change its name to Esperite, it has convened an extra-ordinary
general meeting of shareholders ('EGM') to be held on 2 July 2014, which is
to implement this change and to resolve on the change of the Company's name
to Esperite N.V.

The EGM's convocation notice, agenda and the explanatory notes to the agenda
are available free of charge at the Company's offices in Zutphen, the
Netherlands and can be downloaded from the Company's website,


|Cryo-Save Group + 31 (0) 575 548 998 |
|Frederic Amar, CEO |
About Cryo-Save (

Cryo-Save, the leading international family stem cell bank, stores more than
250,000 samples from umbilical cord blood and cord tissue. There are already
many diseases treatable by the use of stem cells, and the number of
treatments will only increase. Cryo-Save has cryopreserved samples from over
70 countries on six continents, with ultra-modern processing and storage
facilities in Belgium, Germany, Dubai, and South Africa.

Press Release in PDF


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cryo-Save Group N.V. via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.